Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: 165.6B DKK

Novozymes A/S
Other Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Novozymes A/S
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Novozymes A/S
CSE:NZYM B
Other Current Liabilities
kr1.7B
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
N/A
P
Photocat A/S
STO:PCAT
Other Current Liabilities
kr433k
CAGR 3-Years
-7%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
No Stocks Found

Novozymes A/S
Glance View

Market Cap
165.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NZYM B Intrinsic Value
Not Available

See Also

What is Novozymes A/S's Other Current Liabilities?
Other Current Liabilities
1.7B DKK

Based on the financial report for Dec 31, 2023, Novozymes A/S's Other Current Liabilities amounts to 1.7B DKK.

What is Novozymes A/S's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
1%

Over the last year, the Other Current Liabilities growth was 13%. The average annual Other Current Liabilities growth rates for Novozymes A/S have been 10% over the past three years , 1% over the past five years .

Back to Top